Betamethasone- and salicylic acid-containing product in cutaneous dose form
RxNorm 1153783
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1153783 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Betamethasone- and salicylic acid-containing product in cutaneous dose form.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDG
Semantic Clinical Dose Form Group (SCDG):
Betamethasone / salicylic acid Topical Product
(Atom ID: 12287630)
PT
Designated preferred name (PT):
Betamethasone- and salicylic acid-containing product in cutaneous dose form
(Atom ID: 10798061)
FN